Related Experiment Video
Updated: May 11, 2026
09:03
Bioprinting of Cartilage and Skin Tissue Analogs Utilizing a Novel Passive Mixing Unit Technique for Bioink Precellularization
Published on: January 3, 2018
Bioprinting is not cheap
Emma Petiot1, Fabien Guillemot2, Christophe Marquette1
1Université Lyon 1, CNRS, 3d.FAB, ICBMS, UMR 5246, Villeurbanne, France.
Trends in Biotechnology
|May 9, 2026
Abstract:
Bioprinting promises on-demand organs, but the reality is costly. From expensive bioinks and failed prints to clinical translation hurdles, every step demands significant financial and scientific investment. Recognizing these costs upfront is critical for setting realistic expectations, attracting sustainable funding, and driving meaningful progress in the field.
